Lisa A. Carey
- Oncology top 0.02%
- Cancer Research top 0.02%
- Molecular Biology top 0.5%
- Pulmonary and Respiratory Medicine top 0.2%
- Pathology and Forensic Medicine top 0.2%
- Co-authors
- Charles M. PerouCarey K. AndersEric P. WinerChad LivasyMelissa A. TroesterJoseph GeradtsElizabeth Claire DeesMaggie C.U. Cheang
- Topics
- Breast Cancer Treatment Studies (184 papers)HER2/EGFR in Cancer Research (108 papers)Cancer Treatment and Pharmacology (104 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Lisa A. Carey
405 papers receiving 25.4k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Oncology 16.1k
- Cancer Research 12.1k
- Molecular Biology 7.3k
- Pulmonary and Respiratory Medicine 5.4k
- Pathology and Forensic Medicine 3.1k
Countries citing papers authored by Lisa A. Carey
This map shows the geographic impact of Lisa A. Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa A. Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa A. Carey more than expected).
Fields of papers citing papers by Lisa A. Carey
This network shows the impact of papers produced by Lisa A. Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa A. Carey. The network helps show where Lisa A. Carey may publish in the future.
Co-authorship network of co-authors of Lisa A. Carey
This figure shows the co-authorship network connecting the top 25 collaborators of Lisa A. Carey. A scholar is included among the top collaborators of Lisa A. Carey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa A. Carey. Lisa A. Carey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 20 | |
| 5 | 8 | |
| 6 | 0 | |
| 7 | 10 | |
| 8 | 11 | |
| 9 | 16 | |
| 10 | 15 | |
| 11 | 19 | |
| 12 | 27 | |
| 13 | 6 | |
| 14 | 6 | |
| 15 | 194 | |
| 16 | 32 | |
| 17 | 118 | |
| 18 | Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)breakdown → | 650 |
| 19 | 81 | |
| 20 | 56 |
About Lisa A. Carey
Lisa A. Carey is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 421 papers that have together received 25.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (184 papers), HER2/EGFR in Cancer Research (108 papers) and Cancer Treatment and Pharmacology (104 papers). The work is most often cited by research in Cancer Research (12.1k citations), Oncology (16.1k citations) and Pathology and Forensic Medicine (3.1k citations). Lisa A. Carey has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Charles M. Perou, Carey K. Anders, Eric P. Winer, Chad Livasy, Melissa A. Troester, Joseph Geradts, Elizabeth Claire Dees, Maggie C.U. Cheang, Robert C. Millikan and David W. Ollila. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.